EXTRACELLULAR PORTIONS OF EGF RECEPTOR WITH TGFa AND ErbB-2

被引：0
|
作者：
Garrett, P. J. [1 ]
Lou, M. Z. [1 ]
McKern, N. M. [2 ]
Adams, T. E. [2 ]
Lovrecz, G. O. [2 ]
Jorissen, R. N. [3 ]
Nice, E. C. [3 ]
Burgess, A. W. [3 ]
Ward, C. W. [2 ]
机构：
[1] Royal Melbourne Hosp, Post Off, Walter & Eliza Hall Inst, Parkville, Vic 3050, Australia
[2] CSIRO, Div Hlth Sci & Nutr, Canberra, ACT, Australia
[3] Ludwig Inst Canc Res, Zurich, Switzerland
来源：
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 2002年 / 58卷
关键词：
CYTOKINE RECEPTORS COMPLEX CELL SIGNALLING;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：C5 / C5
页数：1
相关论文
共 50 条
  • [41] Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells
    Maria Eugenia Balañá
    Leticia Labriola
    Mariana Salatino
    Federico Movsichoff
    Giselle Peters
    Eduardo H. Charreau
    Patricia V. Elizalde
    Oncogene, 2023, 42 : 3087 - 3087
  • [42] EGF activates ErbB-2 and stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells
    Krymskaya, VP
    Hoffman, R
    Eszterhas, A
    Kane, S
    Ciocca, V
    Panettieri, RA
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (02) : L246 - L255
  • [43] OVEREXPRESSION OF ERBB-2 OR EGF RECEPTOR PROTEINS PRESENT IN EARLY STAGE MAMMARY-CARCINOMA IS DETECTED SIMULTANEOUSLY IN MATCHED PRIMARY TUMORS AND REGIONAL METASTASES
    LACROIX, H
    IGLEHART, JD
    SKINNER, MA
    KRAUS, MH
    ONCOGENE, 1989, 4 (02) : 145 - 151
  • [44] Targeting low-expressing ERBB-2 and acquired resistant high-expressing ERBB-2 breast carcinomas
    Karamouzis, Michalis
    Dalagiorgou, Geena
    Perez, Sonia A.
    Georgopoulou, Urania
    Papavassiliou, Athanasios
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
    Wang, SC
    Lien, HC
    Xia, WY
    Chen, IF
    Lo, HW
    Wang, ZQ
    Ali-Seyed, M
    Lee, DF
    Bartholomeusz, G
    Fu, OY
    Giri, DK
    Hung, MC
    CANCER CELL, 2004, 6 (03) : 251 - 261
  • [46] Testing for erbB-2 by immunohistochemistry in breast cancer
    Allred, DC
    Swanson, PE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) : 171 - 175
  • [47] Effect of GW2016, a dual inhibitor of erbB-2 and EGFR tyrosine receptor kinases, on EGF induced receptor tyrosine autophosphorylation state and downstream signaling pathway.
    Xia, W
    Mullin, R
    Keith, B
    Rusnak, D
    Rhodes, N
    Gilmer, T
    Lackey, K
    Knight, B
    Lucas, S
    Spector, N
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3768S - 3768S
  • [48] Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ERBB-2 receptor
    Houimel, M
    Schneider, P
    Terskikh, A
    Mach, JP
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (05) : 748 - 755
  • [49] Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
    Beguelin, Wendy
    Diaz Flaque, Maria Celeste
    Proietti, Cecilia J.
    Cayrol, Florencia
    Rivas, Martin A.
    Tkach, Mercedes
    Rosemblit, Cinthia
    Tocci, Johanna M.
    Charreau, Eduardo H.
    Schillaci, Roxana
    Elizalde, Patricia V.
    MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (23) : 5456 - 5472
  • [50] SHC PRODUCTS ARE SUBSTRATES OF ERBB-2 KINASE
    SEGATTO, O
    PELICCI, G
    GIULI, S
    DIGIESI, G
    DIFIORE, PP
    MCGLADE, J
    PAWSON, T
    PELICCI, PG
    ONCOGENE, 1993, 8 (08) : 2105 - 2112
12345